SCHEMBL24894644

SCHEMBL24894644

C=C1CN2CCCC2(C(=O)OC)C1

nearest known ligand 0.37

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
PPIA P62937 2/20 0.35
NPSR1 Q6W5P4 1/20 0.32
OPRD1 P41143 1/20 0.30
OPRL1 P41146 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24894502 1.00 PPIA (0.35) PPIANPSR1OPRD1OPRL1
SCHEMBL26981402 0.95 NPSR1 (0.34) PPIANPSR1OPRD1OPRL1
SCHEMBL24649278 0.94 NPSR1 (0.30) NPSR1
SCHEMBL27158501 0.86 PPIA (0.34) PPIANPSR1OPRD1OPRL1
SCHEMBL27125926 0.83
SCHEMBL27158891 0.82 PPIA (0.32) PPIANPSR1OPRL1
SCHEMBL27043819 0.80
SCHEMBL6816556 0.77 NPSR1 (0.41) PPIANPSR1OPRD1OPRL1
SCHEMBL31534320 0.76
SCHEMBL27158933 0.76

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024091409-A1 TRICYCLIC DERIVATIVES AS KRAS INHIBITORS NIKANG THERAPEUTICS, INC. (US) 2024-05-02 WO disclosed
WO-2023284730-A1 ALKYLIDENE DERIVATIVES AS KRAS INHIBITORS NIKANG THERAPEUTICS, INC. (US) 2023-01-19 WO disclosed